{"entity":{"type":"insider","cik":"0001341526","url":"/insider/0001341526","json_url":"/insider/0001341526.json","name":"Day Wesley","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":14,"first":"2006-03-03","last":"2016-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Day Wesley","source":"filing","n_filings":14,"first_seen":"2006-03-03","last_seen":"2016-04-20"}],"transactions":[{"id":8818363,"accession":"0001123292-15-001000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-15-001000","line_url":"/filing/0001123292-15-001000#line-1","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7881.0,"shares_display":"7,881","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":18283.92,"total_display":"18,283.92","total_whole":"18,284","shares_owned_after":49118.0,"shares_owned_after_display":"49,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-06","scope":"insider"},{"id":8595885,"accession":"0001104659-15-005694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-005694","line_url":"/filing/0001104659-15-005694#line-1","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":472.0,"shares_display":"472","price_per_share":2.78,"price_display":"2.78","price_state":"stated","total_value":1312.16,"total_display":"1,312.16","total_whole":"1,312","shares_owned_after":56999.0,"shares_owned_after_display":"56,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-29","filed_date":"2015-01-30","scope":"insider"},{"id":9225515,"accession":"0001123292-16-002113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-002113","line_url":"/filing/0001123292-16-002113#line-1","is_derivative":false,"issuer_cik":"0001341526","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0001341526","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2549.0,"shares_display":"2,549","price_per_share":3.04,"price_display":"3.04","price_state":"stated","total_value":7748.96,"total_display":"7,748.96","total_whole":"7,749","shares_owned_after":46569.0,"shares_owned_after_display":"46,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-01","filed_date":"2016-04-20","scope":"insider"},{"id":2777530,"accession":"0001104659-12-050215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-050215","line_url":"/filing/0001104659-12-050215#line-1","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Research)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16800.0,"shares_display":"16,800","price_per_share":30.36,"price_display":"30.36","price_state":"stated","total_value":510048.0,"total_display":"510,048.00","total_whole":"510,048","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-18","filed_date":"2012-07-20","scope":"insider"},{"id":2385760,"accession":"0001104659-12-012638","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-12-012638","line_url":"/filing/0001104659-12-012638","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79958.0,"shares_display":"79,958","price_per_share":20.69,"price_display":"20.69","price_state":"stated","total_value":1654331.02,"total_display":"1,654,331.02","total_whole":"1,654,331","shares_owned_after":16800.0,"shares_owned_after_display":"16,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-24","scope":"insider","n_lines":3},{"id":3463754,"accession":"0001104659-12-001583","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-12-001583","line_url":"/filing/0001104659-12-001583#line-2","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":345000.0,"total_display":"345,000.00","total_whole":"345,000","shares_owned_after":16800.0,"shares_owned_after_display":"16,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-09","filed_date":"2012-01-11","scope":"insider"},{"id":8982152,"accession":"0001104659-11-064407","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-11-064407","line_url":"/filing/0001104659-11-064407#line-3","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23442.0,"shares_display":"23,442","price_per_share":9.869,"price_display":"9.87","price_state":"stated","total_value":231349.098,"total_display":"231,349.10","total_whole":"231,349","shares_owned_after":16800.0,"shares_owned_after_display":"16,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-11","filed_date":"2011-11-15","scope":"insider"},{"id":9223179,"accession":"0001104659-11-000851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-11-000851","line_url":"/filing/0001104659-11-000851#line-1","is_derivative":false,"issuer_cik":"0001341526","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0001341526","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70600.0,"shares_display":"70,600","price_per_share":9.5389,"price_display":"9.54","price_state":"stated","total_value":673446.34,"total_display":"673,446.34","total_whole":"673,446","shares_owned_after":16800.0,"shares_owned_after_display":"16,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-17","filed_date":"2011-01-07","scope":"insider"},{"id":7701727,"accession":"0001104659-10-063416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-10-063416","line_url":"/filing/0001104659-10-063416#line-2","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66600.0,"shares_display":"66,600","price_per_share":9.5419,"price_display":"9.54","price_state":"stated","total_value":635490.54,"total_display":"635,490.54","total_whole":"635,491","shares_owned_after":20800.0,"shares_owned_after_display":"20,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-17","filed_date":"2010-12-17","scope":"insider"},{"id":3202018,"accession":"0001255442-08-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001255442-08-000023","line_url":"/filing/0001255442-08-000023#line-1","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Research)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3297.0,"shares_display":"3,297","price_per_share":4.1735,"price_display":"4.17","price_state":"stated","total_value":13760.0295,"total_display":"13,760.03","total_whole":"13,760","shares_owned_after":16843.0,"shares_owned_after_display":"16,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-14","filed_date":"2008-05-19","scope":"insider"},{"id":6996335,"accession":"0001255442-07-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001255442-07-000045","line_url":"/filing/0001255442-07-000045#line-1","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Research)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3104.0,"shares_display":"3,104","price_per_share":4.233,"price_display":"4.23","price_state":"stated","total_value":13139.232,"total_display":"13,139.23","total_whole":"13,139","shares_owned_after":13546.0,"shares_owned_after_display":"13,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-14","filed_date":"2007-11-19","scope":"insider"},{"id":7090329,"accession":"0001255442-07-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001255442-07-000022","line_url":"/filing/0001255442-07-000022#line-1","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Research)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4244.0,"shares_display":"4,244","price_per_share":3.06,"price_display":"3.06","price_state":"stated","total_value":12986.64,"total_display":"12,986.64","total_whole":"12,987","shares_owned_after":10442.0,"shares_owned_after_display":"10,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-14","filed_date":"2007-05-22","scope":"insider"},{"id":4605785,"accession":"0001255442-06-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001255442-06-000025","line_url":"/filing/0001255442-06-000025#line-1","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Research)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2198.0,"shares_display":"2,198","price_per_share":2.992,"price_display":"2.99","price_state":"stated","total_value":6576.416,"total_display":"6,576.42","total_whole":"6,576","shares_owned_after":6198.0,"shares_owned_after_display":"6,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-14","filed_date":"2006-11-20","scope":"insider"},{"id":3786784,"accession":"0001255442-06-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001255442-06-000016","line_url":"/filing/0001255442-06-000016#line-1","is_derivative":false,"issuer_cik":"0000881524","issuer_name":"VIVUS INC","issuer_ticker":"VVUS","issuer_name_source":null,"issuer_url":"/issuer/0000881524","owner_cik":"0001341526","owner_name":"Day Wesley","owner_display_name":"Day Wesley","owner_url":"/insider/0001341526","role":"Officer (VP, Clinical Research)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":13600.0,"total_display":"13,600.00","total_whole":"13,600","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-02","filed_date":"2006-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000881524","name":"VIVUS INC","url":"/issuer/0000881524","role":"Officer (VP, Clinical Development)","n_filings":14,"first_seen":"2006-03-03","last_seen":"2016-04-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001341526","retrieved_at":"2026-08-26T22:57:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}